Clinical Research Directory
Browse clinical research sites, groups, and studies.
Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity
Sponsor: University of Colorado, Boulder
Summary
This study tests the effects of cannabinoid levels in blood on inflammation and insulin sensitivity both acutely and chronically in individuals across the weight spectrum. To that end, the study employs two observational designs: 1) A study of acute effects with intermittent cannabis users and 2) A study in which current cannabis users will select one of three cannabis strains for four weeks and are compared to a matched control group who do not use cannabis to study chronic effects. Blood levels of THC and CBD, inflammatory biomarkers, and insulin resistance will be measured in both studies.
Key Details
Gender
All
Age Range
21 Years - 40 Years
Study Type
OBSERVATIONAL
Enrollment
233
Start Date
2019-11-08
Completion Date
2024-12-01
Last Updated
2026-08-06
Healthy Volunteers
Not specified
Interventions
Study A: Single use of cannabis flower product
Participants are asked to purchase and use one of three cannabis flower strains with differing levels of THC and CBD: 1) CBD (\~14% CBD/0% THC), 2) THC (\~14% THC/0% CBD), or 3) THC+CBD (\~7% THC/7% CBD).
Study B: Ad libitum cannabis use for four weeks or no cannabis use
Participants choose whether to use a cannabis flower product ad libitum for four weeks or to not use cannabis for four weeks. Participants who choose to use cannabis are asked to purchase and use one of three cannabis flower strains with differing levels of THC and CBD: 1) CBD (\~14% CBD/0% THC), 2) THC (\~14% THC/0% CBD), or 3) THC+CBD (\~7% THC/7% CBD).
Locations (1)
Center for Innovation and Creativity
Boulder, Colorado, United States